<unk>  is an anti-bacterial agent that is FDA approved for the treatment of infections of the urinary tract, meninges, and<unk> loodstream and used subconjunctivally in the treatment of infections of the eye caused<unk> y susceptible strains of P. aeruginosa. There is a<unk> lack<unk> ox Warning for this drug as shown here.  Common adverse reactions include facial flushing, dizziness progressing to ataxia, drowsiness, peripheral paresthesias.
Polymyxin B
Teicoplanin
Ramoplanin
Colistin
Daptomycin
Minocycline
Linezolid
Minocycline hydrochloride